DNDDF yields 1941.75% · JNJ yields 2.14%● Live data
📍 DNDDF pulled ahead of the other in Year 1
Combined, DNDDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DNDDF + JNJ for your $10,000?
Dundee Sustainable Technologies Inc. engages in the development and commercialization of technologies for the treatment of refractory materials in the mining industry in Canada and internationally. It focuses on the commercialization of CLEVR process, which extracts precious metals, as well as removes and stabilizes contaminants, such as arsenic, antimony, and cadmium; and GlassLock process, which stabilizes arsenic, forms scorodite, and produces an insoluble glass residue that meets environmental requirements. The company extracts precious and base metals from ores, concentrates, and tailings. It also provides technical services to customers in the mining industry to evaluate processing alternatives. The company was formerly known as Nichromet Extraction Inc. and changed its name to Dundee Sustainable Technologies Inc. in January 2014. The company was incorporated in 1997 and is headquartered in Montreal, Canada. Dundee Sustainable Technologies Inc. is a subsidiary of Dundee Corporation.
Full DNDDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.